IBM Watson for Oncology (2013-2022)
IBM's medical AI, built after Watson won Jeopardy, was sold to hospitals as a cancer treatment advisor. MD Anderson cancelled a $62 million project in 2017 after internal documents showed the system produced unsafe treatment recommendations.
Maimonides Medical Center stopped using it; IBM sold off Watson Health in 2022.
Became the cautionary tale for medical AI that dazzles in demos but fails in real clinical settings.
Darwin faces the same question IBM Watson could not answer: whether benchmark mastery survives contact with real patients and real clinician judgment.
